{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:51:39Z","timestamp":1793170299923,"version":"4.5.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,10,12]]},"DOI":"10.1001\/jama.2021.15072","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T11:33:25Z","timestamp":1630668805000},"page":"1390","source":"Crossref","is-referenced-by-count":608,"title":["Surveillance for Adverse Events After COVID-19 mRNA Vaccination"],"prefix":"10.1001","volume":"326","author":[{"given":"Nicola P.","family":"Klein","sequence":"first","affiliation":[{"name":"Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ned","family":"Lewis","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Goddard","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Fireman","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousseny","family":"Zerbo","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla E.","family":"Hanson","sequence":"additional","affiliation":[{"name":"Marshfield Clinic Research Institute, Marshfield, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Donahue","sequence":"additional","affiliation":[{"name":"Marshfield Clinic Research Institute, Marshfield, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse O.","family":"Kharbanda","sequence":"additional","affiliation":[{"name":"HealthPartners Institute, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Naleway","sequence":"additional","affiliation":[{"name":"Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Clark","family":"Nelson","sequence":"additional","affiliation":[{"name":"Biostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Xu","sequence":"additional","affiliation":[{"name":"Research and Evaluation, Kaiser Permanente Southern California, Pasadena"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Katherine","family":"Yih","sequence":"additional","affiliation":[{"name":"Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Glanz","sequence":"additional","affiliation":[{"name":"Institute for Health Research, Kaiser Permanente Colorado, Denver"},{"name":"Department of Epidemiology, Colorado School of Public Health, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua T. B.","family":"Williams","sequence":"additional","affiliation":[{"name":"Ambulatory Care Services, Denver Health, Denver, Colorado"},{"name":"University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Hambidge","sequence":"additional","affiliation":[{"name":"Ambulatory Care Services, Denver Health, Denver, Colorado"},{"name":"University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno J.","family":"Lewin","sequence":"additional","affiliation":[{"name":"Research and Evaluation, Kaiser Permanente Southern California, Pasadena"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom T.","family":"Shimabukuro","sequence":"additional","affiliation":[{"name":"Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"DeStefano","sequence":"additional","affiliation":[{"name":"Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Weintraub","sequence":"additional","affiliation":[{"name":"Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"50","key":"joi210099r1","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","article-title":"The Advisory Committee on Immunization Practices\u2019 interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine\u2014United States, December 2020.","volume":"69","author":"Oliver","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5152","key":"joi210099r2","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.15585\/mmwr.mm695152e1","article-title":"The Advisory Committee on Immunization Practices\u2019 interim recommendation for use of Moderna COVID-19 vaccine\u2014United States, December 2020.","volume":"69","author":"Oliver","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"27","key":"joi210099r3","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine.","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"joi210099r4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"5152","key":"joi210099r5","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.15585\/mmwr.mm695152e2","article-title":"The Advisory Committee on Immunization Practices\u2019 Updated Interim Recommendation for Allocation of COVID-19 vaccine\u2014United States, December 2020.","volume":"69","author":"Dooling","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"joi210099r6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1001\/jama.2020.12190","article-title":"Developing a SARS-CoV-2 vaccine at warp speed.","volume":"324","author":"O\u2019Callaghan","year":"2020","journal-title":"JAMA"},{"key":"joi210099r7","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety.","volume":"127","author":"Baggs","year":"2011","journal-title":"Pediatrics"},{"issue":"10","key":"joi210099r8","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1097\/MLR.0b013e3180616c0a","article-title":"Real-time vaccine safety surveillance for the early detection of adverse events.","volume":"45","author":"Lieu","year":"2007","journal-title":"Med Care"},{"issue":"1","key":"joi210099r9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1542\/peds.2010-0665","article-title":"Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures.","volume":"126","author":"Klein","year":"2010","journal-title":"Pediatrics"},{"issue":"6","key":"joi210099r10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa1311738","article-title":"Risk of intussusception after monovalent rotavirus vaccination.","volume":"370","author":"Weintraub","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"joi210099r11","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1808","article-title":"Near real-time surveillance to assess the safety of the 9-valent human papillomavirus vaccine.","volume":"144","author":"Donahue","year":"2019","journal-title":"Pediatrics"},{"issue":"32","key":"joi210099r12","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.15585\/mmwr.mm7032a2","article-title":"Alternative methods for grouping race and ethnicity to monitor COVID-19 outcomes and vaccination coverage.","volume":"70","author":"Yoon","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"28","key":"joi210099r13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.15585\/mmwr.mm7028a1","article-title":"COVID-19 vaccination coverage among insured persons aged =16 years, by race\/ethnicity and other selected characteristics\u2014eight integrated health care organizations, United States, December 14, 2020\u2013May 15, 2021.","volume":"70","author":"Pingali","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"joi210099r16","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-052478","article-title":"Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination.","author":"Marshall","year":"2021","journal-title":"Pediatrics"},{"issue":"31","key":"joi210099r17","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.","volume":"25","author":"R\u00fcggeberg","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"joi210099r18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.amepre.2011.04.004","article-title":"H1N1 and seasonal influenza vaccine safety in the Vaccine Safety Datalink project.","volume":"41","author":"Lee","year":"2011","journal-title":"Am J Prev Med"},{"issue":"8","key":"joi210099r19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Spatial disease clusters: detection and inference.","volume":"14","author":"Kulldorff","year":"1995","journal-title":"Stat Med"},{"issue":"2","key":"joi210099r20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/biomet\/64.2.191","article-title":"Group sequential methods in the design and analysis of clinical trials.","volume":"64","author":"Pocock","year":"1977","journal-title":"Biometrika"},{"issue":"8","key":"joi210099r21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.15585\/mmwr.mm7008e3","article-title":"First month of COVID-19 vaccine safety monitoring\u2014United States, December 14, 2020\u2013January 13, 2021.","volume":"70","author":"Gee","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"22","key":"joi210099r22","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination.","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"n1114","key":"joi210099r23","doi-asserted-by":"crossref","first-page":"n1114","DOI":"10.1136\/bmj.n1114","article-title":"Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.","volume":"373","author":"Potteg\u00e5rd","year":"2021","journal-title":"BMJ"},{"issue":"6","key":"joi210099r24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1161\/CIRCULATIONAHA.121.056038","article-title":"In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine.","volume":"144","author":"Muthukumar","year":"2021","journal-title":"Circulation"},{"issue":"3","key":"joi210099r25","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults.","volume":"137","author":"McNeil","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"joi210099r26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.15585\/mmwr.mm7002e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine\u2014United States, December 14-23, 2020.","volume":"70","author":"CDC COVID-19 Response Team","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"joi210099r27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US\u2014December 14, 2020\u2013January 18, 2021.","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"issue":"15","key":"joi210099r28","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1001\/jama.2021.3976","article-title":"Acute allergic reactions to mRNA COVID-19 vaccines.","volume":"325","author":"Blumenthal","year":"2021","journal-title":"JAMA"},{"issue":"25","key":"joi210099r29","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1016\/j.vaccine.2021.04.066","article-title":"Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines.","volume":"39","author":"Somiya","year":"2021","journal-title":"Vaccine"},{"issue":"4","key":"joi210099r30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041535","article-title":"Sex and gender aspects for patient stratification in allergy prevention and treatment.","volume":"21","author":"De Martinis","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"joi210099r31","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S1473-3099(21)00076-1","article-title":"Bell\u2019s palsy and SARS-CoV-2 vaccines.","volume":"21","author":"Ozonoff","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"joi210099r32","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2021.2219","article-title":"Association of facial paralysis with mRNA COVID-19 vaccines: a disproportionality analysis using the World Health Organization pharmacovigilance database.","author":"Renoud","year":"2021","journal-title":"JAMA Intern Med"},{"key":"joi210099r14","unstructured":"Cases of cerebral venous sinus thrombosis with thrombocytopenia after receipt of the Johnson & Johnson COVID-19 vaccine. Centers for Disease Control and Prevention. Published April 13, 2021. Accessed April 20, 2021. https:\/\/emergency.cdc.gov\/han\/2021\/han00442.asp"},{"key":"joi210099r15","unstructured":"EMA raises awareness of clinical care recommendations to manage suspected thrombosis with thrombocytopenia syndrome. European Medicines Agency. Published June 7, 2021. Accessed June 29, 2021. https:\/\/www.ema.europa.eu\/en\/news\/ema-raises-awareness-clinical-care-recommendations-manage-suspected-thrombosis-thrombocytopenia"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2784015\/jama_klein_2021_oi_210099_1633976015.05985.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T17:31:48Z","timestamp":1634491908000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2784015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":32,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021,10,12]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.15072","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,12]]}}}